This inventor holds 1 USPTO granted patent. Top assignee: Life Technologies Corporation. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: Innovations by Shoeb Khan in Nucleic Acid Synthesis
Introduction
Shoeb Khan is an accomplished inventor based in Foster City, CA (US). He has made significant contributions to the field of biotechnology, particularly in the area of nucleic acid synthesis. His innovative work has led to the development of unique nucleotide analogs that enhance the efficiency of DNA sequencing methods.
Latest Patents
Shoeb Khan holds a patent for "Unnatural polymerase substrates that can sustain enzymatic synthesis of double stranded nucleic acids from a nucleic acid template and methods of use." This patent describes nucleotide analogs that facilitate the enzymatic synthesis of double-stranded nucleic acids from a nucleic acid template. The nucleotide analogs include a base selected from adenine, guanine, cytosine, thymine, uracil, and their analogs. Additionally, these analogs feature a label attached to the base via a cleavable linker, a deoxyribose, and one or more phosphate groups. The innovative design allows for the use of these nucleotide analogs as reversible terminators in sequencing by synthesis methods without blocking the 3' hydroxyl group.
Career Highlights
Shoeb Khan is currently employed at Life Technologies Corporation, where he continues to advance research in nucleic acid technologies. His work has been pivotal in developing methods that improve the accuracy and efficiency of DNA sequencing, which is crucial for various applications in genomics and molecular biology.
Collaborations
Throughout his career, Shoeb Khan has collaborated with notable colleagues, including Paul M. Kenney and Barnett B. Rosenblum. These collaborations have further enriched his research and contributed to the advancement of innovative solutions in the field.
Conclusion
Shoeb Khan's contributions to the field of biotechnology, particularly through his patent on nucleotide analogs, demonstrate his commitment to advancing nucleic acid synthesis technologies. His work at Life Technologies Corporation continues to impact the scientific community positively.